Latest Insider Transactions at Moelis & CO (MC)
This section provides a real-time view of insider transactions for Moelis & CO (MC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Moelis & Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Moelis & Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 07
2025
|
Kenneth Moelis Chairman, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2
+0.0%
|
-
|
|
Feb 21
2025
|
Kenneth Shropshire |
SELL
Open market or private sale
|
Direct |
2,551
-26.88%
|
$183,672
$72.3 P/Share
|
|
Feb 19
2025
|
Ciafone Katherine Pilcher Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,515
-47.19%
|
$260,110
$74.0 P/Share
|
|
Feb 19
2025
|
Ciafone Katherine Pilcher Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1
-0.01%
|
$74
$74.0 P/Share
|
|
Feb 19
2025
|
Ciafone Katherine Pilcher Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,450
+50.0%
|
-
|
|
Feb 19
2025
|
Joseph Simon Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,758
-20.14%
|
$426,092
$74.0 P/Share
|
|
Feb 19
2025
|
Joseph Simon Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1
-0.0%
|
$74
$74.0 P/Share
|
|
Feb 19
2025
|
Joseph Simon Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,824
+29.26%
|
-
|
|
Feb 19
2025
|
Eric Cantor Vice Chairman, MD |
SELL
Open market or private sale
|
Direct |
16,530
-7.02%
|
$1,223,220
$74.0 P/Share
|
|
Feb 19
2025
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
1
-0.0%
|
$74
$74.0 P/Share
|
|
Feb 19
2025
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
37,612
+13.78%
|
-
|
|
Feb 19
2025
|
Osamu R. Watanabe General Counsel, Secretary |
SELL
Open market or private sale
|
Direct |
5,661
-46.66%
|
$418,914
$74.0 P/Share
|
|
Feb 19
2025
|
Osamu R. Watanabe General Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2
-0.02%
|
$148
$74.0 P/Share
|
|
Feb 19
2025
|
Osamu R. Watanabe General Counsel, Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
12,003
+49.73%
|
-
|
|
Feb 19
2025
|
Jeffrey Raich Co-President, MD |
SELL
Open market or private sale
|
Direct |
8,722
-13.73%
|
$645,428
$74.0 P/Share
|
|
Feb 19
2025
|
Jeffrey Raich Co-President, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
0
|
$0
$74.0 P/Share
|
|
Feb 19
2025
|
Jeffrey Raich Co-President, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
18,757
+22.8%
|
-
|
|
Feb 19
2025
|
Christopher Callesano Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,282
-51.1%
|
$94,868
$74.0 P/Share
|
|
Feb 19
2025
|
Christopher Callesano Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2
-0.08%
|
$148
$74.0 P/Share
|
|
Feb 19
2025
|
Christopher Callesano Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,511
+50.0%
|
-
|
|
Feb 19
2025
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Direct |
9,712
-4.44%
|
$718,688
$74.0 P/Share
|
|
Feb 19
2025
|
Kenneth Moelis Chairman, CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
0
|
$0
$74.0 P/Share
|
|
Feb 19
2025
|
Kenneth Moelis Chairman, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
58,860
+21.19%
|
-
|
|
Feb 19
2025
|
Navid Mahmoodzadegan Co-President, MD |
SELL
Open market or private sale
|
Direct |
9,406
-4.54%
|
$696,044
$74.0 P/Share
|
|
Feb 19
2025
|
Navid Mahmoodzadegan Co-President, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
0
|
$0
$74.0 P/Share
|
|
Feb 19
2025
|
Navid Mahmoodzadegan Co-President, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
57,008
+21.59%
|
-
|
|
Feb 18
2025
|
Joseph Simon Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,767
+50.0%
|
-
|
|
Feb 18
2025
|
Kenneth Moelis Chairman, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
160,001
+24.99%
|
-
|
|
Feb 18
2025
|
Navid Mahmoodzadegan Co-President, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
150,000
+50.0%
|
-
|
|
Feb 18
2025
|
Jeffrey Raich Co-President, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
44,759
+50.0%
|
-
|
|
Feb 06
2025
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
385
-0.19%
|
$30,415
$79.68 P/Share
|
|
Feb 06
2025
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
876
+0.44%
|
-
|
|
Dec 03
2024
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
1,355
-0.68%
|
$101,625
$75.81 P/Share
|
|
Dec 03
2024
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
1,355
+0.68%
|
-
|
|
Dec 02
2024
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
6
+0.74%
|
-
|
|
Dec 02
2024
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.76%
|
-
|
|
Dec 02
2024
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
19
+0.76%
|
-
|
|
Dec 02
2024
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
1
+0.54%
|
-
|
|
Dec 02
2024
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.77%
|
-
|
|
Dec 02
2024
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
20
+0.76%
|
-
|
|
Dec 02
2024
|
Louise Mirrer |
BUY
Grant, award, or other acquisition
|
Direct |
9
+0.74%
|
-
|
|
Dec 02
2024
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct |
6
+0.74%
|
-
|
|
Dec 02
2024
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.76%
|
-
|
|
Dec 02
2024
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct |
19
+0.76%
|
-
|
|
Nov 07
2024
|
Christopher Callesano Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
885
-100.0%
|
$70,800
$80.0 P/Share
|
|
Oct 24
2024
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
391
-0.2%
|
$26,588
$68.24 P/Share
|
|
Oct 24
2024
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
890
+0.45%
|
-
|
|
Sep 26
2024
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
9
+0.83%
|
-
|
|
Sep 26
2024
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.81%
|
-
|
|
Sep 26
2024
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
21
+0.85%
|
-
|